Literature DB >> 35290595

Discovery and repurposing of artemisinin.

Qiaoli Shi1, Fei Xia1, Qixin Wang1, Fulong Liao1, Qiuyan Guo2, Chengchao Xu3,4, Jigang Wang5,6,7,8.   

Abstract

Malaria is an ancient infectious disease that threatens millions of lives globally even today. The discovery of artemisinin, inspired by traditional Chinese medicine (TCM), has brought in a paradigm shift and been recognized as the "best hope for the treatment of malaria" by World Health Organization. With its high potency and low toxicity, the wide use of artemisinin effectively treats the otherwise drug-resistant parasites and helps many countries, including China, to eventually eradicate malaria. Here, we will first review the initial discovery of artemisinin, an extraordinary journey that was in stark contrast with many drugs in western medicine. We will then discuss how artemisinin and its derivatives could be repurposed to treat cancer, inflammation, immunoregulation-related diseases, and COVID-19. Finally, we will discuss the implications of the "artemisinin story" and how that can better guide the development of TCM today. We believe that artemisinin is just a starting point and TCM will play an even bigger role in healthcare in the 21st century.
© 2022. Higher Education Press.

Entities:  

Keywords:  COVID-19; artemisinin; cancer; drug repurposing; inflammation; traditional Chinese medicine

Mesh:

Substances:

Year:  2022        PMID: 35290595      PMCID: PMC8922983          DOI: 10.1007/s11684-021-0898-6

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   9.927


  62 in total

Review 1.  Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives.

Authors:  Xin Sun; Peiyi Yan; Chang Zou; Yin-Kwan Wong; Yuhan Shu; Yew Mun Lee; Chongjing Zhang; Nai-Di Yang; Jigang Wang; Jianbin Zhang
Journal:  Med Res Rev       Date:  2019-04-11       Impact factor: 12.944

2.  Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling.

Authors:  M Ilamathi; P C Prabu; K Ashok Ayyappa; V Sivaramakrishnan
Journal:  Biomed Pharmacother       Date:  2016-05-06       Impact factor: 6.529

3.  Suboptimal dosing triggers artemisinin partner drug resistance.

Authors:  Jigang Wang; Chengchao Xu; Fu Long Liao; Tingliang Jiang; Sanjeev Krishna; Youyou Tu
Journal:  Lancet Infect Dis       Date:  2019-11       Impact factor: 25.071

Review 4.  From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy.

Authors:  Thomas Efferth
Journal:  Semin Cancer Biol       Date:  2017-02-28       Impact factor: 15.707

5.  Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells.

Authors:  H J Woerdenbag; T A Moskal; N Pras; T M Malingré; F S el-Feraly; H H Kampinga; A W Konings
Journal:  J Nat Prod       Date:  1993-06       Impact factor: 4.050

6.  Artesunate Activates the Intrinsic Apoptosis of HCT116 Cells through the Suppression of Fatty Acid Synthesis and the NF-κB Pathway.

Authors:  Xiao Chen; Yin Kwan Wong; Teck Kwang Lim; Wei Hou Lim; Qingsong Lin; Jigang Wang; Zichun Hua
Journal:  Molecules       Date:  2017-08-08       Impact factor: 4.411

Review 7.  Direct Targeting Options for STAT3 and STAT5 in Cancer.

Authors:  Anna Orlova; Christina Wagner; Elvin D de Araujo; Dávid Bajusz; Heidi A Neubauer; Marco Herling; Patrick T Gunning; György M Keserű; Richard Moriggl
Journal:  Cancers (Basel)       Date:  2019-12-03       Impact factor: 6.639

8.  The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling.

Authors:  Fang-Ming Yang; Di Fan; Xiao-Qian Yang; Feng-Hua Zhu; Mei-Juan Shao; Qian Li; Yu-Ting Liu; Ze-Min Lin; Shi-Qi Cao; Wei Tang; Shi-Jun He; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2020-08-03       Impact factor: 6.150

9.  Dihydroartemisinin Prevents Distant Metastasis of Laryngeal Carcinoma by Inactivating STAT3 in Cancer Stem Cells.

Authors:  Weiyi Wang; Yajing Sun; Xiaoming Li; Xinli Shi; Zhen Li; Xiuying Lu
Journal:  Med Sci Monit       Date:  2020-03-16

10.  Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.

Authors:  Mathieu Gendrot; Isabelle Duflot; Manon Boxberger; Océane Delandre; Priscilla Jardot; Marion Le Bideau; Julien Andreani; Isabelle Fonta; Joel Mosnier; Clara Rolland; Sébastien Hutter; Bernard La Scola; Bruno Pradines
Journal:  Int J Infect Dis       Date:  2020-08-14       Impact factor: 3.623

View more
  1 in total

Review 1.  Advocacy for the Medicinal Plant Artabotrys hexapetalus (Yingzhao) and Antimalarial Yingzhaosu Endoperoxides.

Authors:  Christian Bailly; Jean-Pierre Hénichart
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.